Brophy Gerard
Officer at AVTR
- Sold, on record
- $22.2M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Mar 3, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AVTRAvantor, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AVTRUnusualJan 5, 2022 2022
Sold 70,969 shares at $40.42 ($2.9M)
Brophy Gerard, EVP, Biopharma Production
Sold 35.1% of holdings ($8.2M position)131,312 shares left3.1x usual sizeFiling
- 2 Form 4 sale AVTRPlan not statedFeb 23, 2022 +49 days
Sold 3,059 shares at $33.79 ($103k)
Brophy Gerard, EVP, Biopharma Production
Sold 2.4% of holdings ($4.3M position)125,181 shares left0.1x usual sizeFiling
- 3 Form 4 sale AVTRPlan not statedMar 1, 2022 +6 days
Sold 2,027 shares at $34.47 ($70k)
Brophy Gerard, EVP, Biopharma Production
Sold 1.5% of holdings ($4.8M position)136,221 shares left0.1x usual sizeFiling
- 4 Form 4 sale AVTRPlan not statedMay 20, 2022 +80 days
Sold 19,603 shares at $31.27 ($613k)
Brophy Gerard, EVP, Biopharma Production
Sold 16.8% of holdings ($3.6M position)96,935 shares left1x usual sizeFiling
- 5 Form 4 sale AVTRPlan not statedFeb 2, 2023 +258 days
Sold 11,339 shares at $25.06 ($284k)
Brophy Gerard, EVP, Biopharma Production
Sold 10% of holdings ($2.8M position)102,385 shares left0.6x usual sizeFiling
- 6 Form 4 sale AVTRPlan not statedFeb 27, 2023 +25 days
Sold 3,059 shares at $25.00 ($76k)
Brophy Gerard, EVP, Biopharma Production
Sold 2.6% of holdings ($2.9M position)112,629 shares left0.2x usual sizeFiling
- 7 Form 4 sale AVTRPlan not statedMar 3, 2023 +4 days
Sold 3,914 shares at $25.00 ($98k)
Brophy Gerard, EVP, Biopharma Production
Sold 3.5% of holdings ($2.8M position)108,715 shares left0.3x usual sizeFiling
- 8 Form 144 notice AVTRNoticeMar 1, 2024 +364 days
Filed to sell 232,267 shares ($5.8M)
Brophy Gerard, Officer
10b5-1 plan30.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Mar 1, 2024 | AVTR | Officer | Form 144 notice | 232,267 | $5.8M | Notice | SEC | |
| Mar 3, 2023 | Mar 6, 2023 | AVTR | EVP, Biopharma Production | Form 4 sale | 3,914 | $98k | 3.5% | Plan not stated | SEC |
| Feb 27, 2023 | Mar 1, 2023 | AVTR | EVP, Biopharma Production | Form 4 sale | 3,059 | $76k | 2.6% | Plan not stated | SEC |
| Feb 2, 2023 | Feb 2, 2023 | AVTR | EVP, Biopharma Production | Form 4 sale | 11,339 | $284k | 10.0% | Plan not stated | SEC |
| May 20, 2022 | May 23, 2022 | AVTR | EVP, Biopharma Production | Form 4 sale | 19,603 | $613k | 16.8% | Plan not stated | SEC |
| Mar 1, 2022 | Mar 2, 2022 | AVTR | EVP, Biopharma Production | Form 4 sale | 2,027 | $70k | 1.5% | Plan not stated | SEC |
| Feb 23, 2022 | Feb 25, 2022 | AVTR | EVP, Biopharma Production | Form 4 sale | 3,059 | $103k | 2.4% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 5, 2022 | AVTR | EVP, Biopharma Production | Form 4 sale | 70,969 | $2.9M | 35.1% | Unusual | SEC |
| Jul 30, 2021 | Aug 2, 2021 | AVTR | EVP, Biopharma Production | Form 4 sale | 81,125 | $3M | 35.2% | Unusual | SEC |
| May 20, 2021 | May 21, 2021 | AVTR | EVP, Biopharma Production | Form 4 sale | 19,603 | $610k | 11.6% | Plan not stated | SEC |
| Feb 24, 2021 | Feb 26, 2021 | AVTR | EVP, Biopharma Production | Form 4 sale | 3,059 | $85k | 1.7% | Plan not stated | SEC |
| Feb 22, 2021 | Feb 23, 2021 | AVTR | EVP, Biopharma Production | Form 4 sale | 19,769 | $566k | 10.1% | Plan not stated | SEC |
| Jan 11, 2021 | Jan 13, 2021 | AVTR | EVP, Biopharma Production | Form 4 sale | 378,580 | $11.4M | 68.0% | Unusual | SEC |
| Jan 6, 2021 | Jan 8, 2021 | AVTR | EVP, Biopharma Production | Form 4 sale | 11,509 | $314k | 6.1% | Plan not stated | SEC |
| Jan 4, 2021 | Jan 6, 2021 | AVTR | EVP, Biopharma Production | Form 4 sale | 59,418 | $1.7M | 23.8% | Plan not stated | SEC |
| May 20, 2020 | May 22, 2020 | AVTR | EVP, Biopharma Production | Form 4 sale | 25,495 | $443k | 11.5% | Plan not stated | SEC |